KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Revenue (2016 - 2025)

Opko Health (OPK) has disclosed Revenue for 16 consecutive years, with $148.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 19.16% year-over-year to $148.5 million, compared with a TTM value of $606.9 million through Dec 2025, up 7.68%, and an annual FY2025 reading of $606.9 million, down 14.9% over the prior year.
  • Revenue was $148.5 million for Q4 2025 at Opko Health, down from $151.7 million in the prior quarter.
  • Across five years, Revenue topped out at $545.2 million in Q1 2021 and bottomed at -$815.9 million in Q4 2022.
  • Average Revenue over 5 years is $171.3 million, with a median of $179.2 million recorded in 2022.
  • Peak annual rise in Revenue hit 17874.4% in 2022, while the deepest fall reached 303.29% in 2022.
  • Year by year, Revenue stood at $401.3 million in 2021, then tumbled by 303.29% to -$815.9 million in 2022, then surged by 151.11% to $417.0 million in 2023, then tumbled by 55.96% to $183.6 million in 2024, then dropped by 19.16% to $148.5 million in 2025.
  • Business Quant data shows Revenue for OPK at $148.5 million in Q4 2025, $151.7 million in Q3 2025, and $156.8 million in Q2 2025.